We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Memory Pharmaceuticals and Roche Expand Development Program for MEM 3454 in Schizophrenia

News   Feb 20, 2008

 
Memory Pharmaceuticals and Roche Expand Development Program for MEM 3454 in Schizophrenia
 
 
 

RELATED ARTICLES

Biosynthetic Pathway in Bacteria a Recipe for Drug Discovery

News

Microbes are the "master chefs" of the biomolecular world; collectively, they harbor the ability to produce a vast array of unknown substances, some of which may have therapeutic or other useful properties. In searching for useful products, a team of chemists have uncovered a whole new class of microbial recipes.

READ MORE

Diving Deeper Into the Metabolism of the Autistic Brain

News

Scientists looked into the differences in the concentrations of multiple metabolites in healthy humans and individuals suffering from Autism Spectrum Disorder (ASD), gaining a deeper insight into the molecular processes that take place in the brain of autistic individuals.

READ MORE

Disease Biomarker Identification: The Zoo Animals Doing Their Bit for Science

News

Researchers want to use similar genetic patterns, which have been present in the blood of humans and animals for thousands of years, to improve computer-assisted disease prognosis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE